A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The GRADE Study is a pragmatic, unmasked clinical trial that will compare commonly used
diabetes medications, when combined with metformin, on glycemia-lowering effectiveness and
patient-centered outcomes.
Phase:
Phase 3
Details
Lead Sponsor:
GRADE Study Group
Collaborators:
Becton, Dickinson and Company Bristol-Myers Squibb Centers for Disease Control and Prevention Hoffmann-La Roche Merck Sharp & Dohme Corp. National Heart, Lung, and Blood Institute (NHLBI) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Novo Nordisk A/S Roche Diagnostics Sanofi